Colorectal cancer in the very young: a comparative study of tumor markers, pathology and survival in early onset and adult onset patients

Journal of Pediatric Surgery

Volumn 51, Issue 11, 2016, Pages 1812-1817

  Khan, Sajid A ^a,b   Morris, Melinda ^c   Idrees, Kamran ^b   Gimbel, Mark I ^b   Rosenberg, Shoshana ^b   Zeng, Zhaoshi ^b   Li, Fangyong ^a   Gan, Geliang ^a   Shia, Jinru ^b   LaQuaglia, Michael P ^b   Paty, Philip B ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

BRAF; Early onset colorectal cancer; MSI

Indexed keywords

B RAF KINASE; MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; TUMOR MARKER; DNA; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT; CLINICAL FEATURE; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENE MUTATION; GENOTYPE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; ONSET AGE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ADOLESCENT; CHILD; COLORECTAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; EPIDEMIOLOGY; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; MUTATION; SURVIVAL RATE; TRENDS; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CHILD; COLORECTAL NEOPLASMS; DNA MISMATCH REPAIR; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTATION; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; UNITED STATES; YOUNG ADULT;

EID: 84991383859     PISSN: 00223468     EISSN: 15315037     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2016.07.015     Document Type: Article

References (50)

1. [1] Surveillance, epidemiology, and end results program database. http://seer.cancer.gov/ [Accessed June 30, 2015].
2. [2] LaQuaglia, MP, Heller, G, Filippa, DA, et al. Prognostic factors and outcome in patients 21 years and under with colorectal carcinoma. J Pediatr Surg 27:8 (1992), 1085–1089 [discussion 1089-90].
3. [3] Vastyan, AM, Walker, J, Pinter, AB, et al. Colorectal carcinoma in children and adolescents—a report of seven cases. Eur J Pediatr Surg 11:5 (2001), 338–341.
4. [4] Singh, Y, Vaidya, P, Hemandas, AK, et al. Colorectal carcinoma in nepalese young adults: presentation and outcome. Gan To Kagaku Ryoho 29:Suppl. 1 (2002), 223–229.
5. [5] Hill, DA, Furman, WL, Billups, CA, et al. Colorectal carcinoma in childhood and adolescence: a clinicopathologic review. J Clin Oncol 25:36 (2007), 5808–5814.
6. [6] Kam, MH, Eu, KW, Barben, CP, et al. Colorectal cancer in the young: a 12-year review of patients 30 years or less. Colorectal Dis 6:3 (2004), 191–194.
7. [7] Abou-Zeid, AA, Khafagy, W, Marzouk, DM, et al. Colorectal cancer in Egypt. Dis Colon Rectum 45:9 (2002), 1255–1260.
8. [8] Al-Jaberi, TM, Yaghan, RJ, El-Heis, HA, Colorectal cancer in young patients under 40 years of age. Comparison with old patients in a well defined jordanian population. Saudi Med J 24:8 (2003), 871–874.
9. [9] Sultan, I, Rodriguez-Galindo, C, El-Taani, H, et al. Distinct features of colorectal cancer in children and adolescents. Cancer 116:3 (2010), 758–765.
10. [10] Takai, S, Yamamura, M, Sakaguchi, M, et al. Carcinoma of the colon in children: report of a case and review of the literature. Jpn J Surg 18:3 (1988), 341–345.
11. [11] Kubota, K, Akasu, T, Fujita, S, et al. Clinical and pathological prognostic indicators with colorectal mucinous carcinomas. Hepatogastroenterology 51:55 (2004), 142–146.
12. [12] Dunlop, MG, Wyllie, AH, Steel, CM, et al. Linked DNA markers for presymptomatic diagnosis of familial adenomatous polyposis. Lancet 337:8737 (1991), 313–316.
13. [13] Farrington, SM, Lin-Goerke, J, Ling, J, et al. Systematic analysis of hMSH2 and hMLH1 in young colon cancer patients and controls. Am J Hum Genet 63:3 (1998), 749–759.
14. [14] Datta, RV, LaQuaglia, MP, Paty, PB, Genetic and phenotypic correlates of colorectal cancer in young patients. N Engl J Med 342:2 (2000), 137–138.
15. [15] Shia, J, Ellis, NA, Paty, PB, et al. Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer. Am J Surg Pathol 27:11 (2003), 1407–1417.
16. [16] Kochl, S, Niederstatter, H, Parson, W, DNA extraction and quantitation of forensic samples using the phenol–chloroform method and real-time PCR. Methods Mol Biol 297 (2005), 13–30.
17. [17] Nash, GM, Gimbel, M, Shia, J, et al. Automated, multiplex assay for high-frequency microsatellite instability in colorectal cancer. J Clin Oncol 21:16 (2003), 3105–3112.
18. [18] Khanna, M, Park, P, Zirvi, M, et al. Multiplex PCR/LDR for detection of K-ras mutations in primary colon tumors. Oncogene 18:1 (1999), 27–38.
19. [19] Turner, DJ, Zirvi, MA, Barany, F, et al. Detection of the BRAF V600E mutation in melanocytic lesions using the ligase detection reaction. J Cutan Pathol 32:5 (2005), 334–339.
20. [20] Shia, J, Klimstra, DS, Nafa, K, et al. Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms. Am J Surg Pathol 29:1 (2005), 96–104.
21. [21] Diep, CB, Thorstensen, L, Meling, GI, et al. Genetic tumor markers with prognostic impact in Dukes’ stages B and C colorectal cancer patients. J Clin Oncol 21:5 (2003), 820–829.
22. [22] Lukish, JR, Muro, K, DeNobile, J, et al. Prognostic significance of DNA replication errors in young patients with colorectal cancer. Ann Surg 227:1 (1998), 51–56.
23. [23] Marra, G, Boland, CR, Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst 87:15 (1995), 1114–1125.
24. [24] Gatalica, Z, Torlakovic, E, Pathology of the hereditary colorectal carcinoma. Fam Cancer 7:1 (2008), 15–26.
25. [25] Al-Sukhni, W, Aronson, M, Gallinger, S, Hereditary colorectal cancer syndromes: familial adenomatous polyposis and Lynch syndrome. Surg Clin North Am 88:4 (2008), 819–844.
26. [26] Lynch, HT, Lynch, JF, Lynch, PM, et al. Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management. Fam Cancer 7:1 (2008), 27–39.
27. [27] Jass, JR, Familial colorectal cancer: pathology and molecular characteristics. Lancet Oncol 1 (2000), 220–226.
28. [28] Jenkins, MA, Dowty, JG, Hopper, JL, et al. Molecular screening of all colorectal tumors diagnosed before age 50 years followed by genetic testing efficiently identifies Lynch syndrome cases. Int J Cancer, 124(5), 2009.
29. [29] Nilbert, M, Timshel, S, Bernstein, I, et al. Role for genetic anticipation in Lynch syndrome. J Clin Oncol 27:3 (2009), 360–364.
30. [30] Leff, DR, Chen, A, Roberts, D, et al. Colorectal cancer in the young patient. Am Surg 73:1 (2007), 42–47.
31. [31] Moisio, AL, Jarvinen, H, Peltomaki, P, Genetic and clinical characterisation of familial adenomatous polyposis: a population based study. Gut 50:6 (2002), 845–850.
32. [32] Poynter, JN, Siegmund, KD, Weisenberger, DJ, et al. Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening. Cancer Epidemiol Biomarkers Prev 17:11 (2008), 3208–3215.
33. [33] Bettstetter, M, Dechant, S, Ruemmele, P, et al. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR. Clin Cancer Res 13:11 (2007), 3221–3228.
34. [34] Hitchins, MP, Lin, VA, Buckle, A, et al. Epigenetic inactivation of a cluster of genes flanking MLH1 in microsatellite-unstable colorectal cancer. Cancer Res 67:19 (2007), 9107–9116.
35. [35] Lubomierski, N, Plotz, G, Wormek, M, et al. BRAF mutations in colorectal carcinoma suggest two entities of microsatellite-unstable tumors. Cancer 104:5 (2005), 952–961.
36. [36] Deng, G, Bell, I, Crawley, S, et al. BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer. Clin Cancer Res 10:1 Pt 1 (2004), 191–195.
37. [37] Loughrey, MB, Waring, PM, Tan, A, et al. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer. Fam Cancer 6:3 (2007), 301–310.
38. [38] Kune, GA, Kune, S, Field, B, et al. Survival in patients with large-bowel cancer. A population-based investigation from the Melbourne colorectal cancer study. Dis Colon Rectum 33:11 (1990), 938–946.
39. [39] Raymond, PL, Skelton, DS, Hsu, HS, Young patients with colorectal cancer: the University of Mississippi medical center experience 1970–1990. J Miss State Med Assoc 32:8 (1991), 298–304.
40. [40] Maestro, ML, Vidaurreta, M, Sanz-Casla, MT, et al. Role of the BRAF mutations in the microsatellite instability genetic pathway in sporadic colorectal cancer. Ann Surg Oncol 14:3 (2007), 1229–1236.
41. [41] Samowitz, WS, Sweeney, C, Herrick, J, et al. Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res 65:14 (2005), 6063–6069.
42. [42] Barault, L, Charon-Barra, C, Jooste, V, et al. Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. Cancer Res 68:20 (2008), 8541–8546.
43. [43] Salas-Valverde, S, Lizano, A, Gamboa, Y, et al. Colon carcinoma in children and adolescents: prognostic factors and outcome—review of 11 cases. Pediatr Surg Int 25 (2009), 1073–1076.
44. [44] Ferrari, A, Rognone, A, Casanova, M, et al. Colorectal carcinoma in children and adolescents: the experience of the Istituto Nazionale Tumori of Milan, Italy. Pediatr Blood Cancer 50 (2008), 588–593.
45. [45] Hegde, M, Ferber, M, Mao, R, et al. ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (Lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis). Genet Med 16:1 (2014), 101–116.
46. [46] Martin-Lopez, JV, Fischel, R, The mechanism of mismatch repair and the functional analysis of mismatch repair defects in Lynch syndrome. Fam Cancer 12:2 (2013), 159–168.
47. [47] Myers, EA, Feingold, DL, Forde, KA, et al. Colorectal cancer in patients under 50 years of age: a retrospective analysis of two institutions’ experience. World J Gastroenterol 19:34 (2013), 5651–5657.
48. [48] Valle, L, Hernandez-Illan, E, Bellido, F, et al. New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis. Hum Mol Genet 23:13 (2014), 3506–3512.
49. [49] Minoo, P, Moyer, MP, Jass, JR, Role of BRAF–V600E in the serrated pathway of colorectal tumourigenesis. J Pathol 212 (2007), 124–133.
50. [50] Lochhead, P, Kuchiba, A, Imamura, Y, et al. Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication. J Natl Cancer Inst 105 (2013), 1151–1156.